Media Coverage

2020

20/10/2020

Proteomics signs deal for distribution of PromarkerD in Italy – Biotech Dispatch

16/10/2020

Proteomics strikes kidney disease test deal in Italy – The West Australian

16/10/2020

Proteomics International Inks Italian Distribution Deal for Diabetic Kidney Disease Immunoassay – 360Dx

16/10/2020

Proteomics International Laboratories (ASX:PIQ) signs distribution deal for diabetic kidney disease – The Market Herald

12/10/2020

The West Australian – Major clinical study validates Proteomics kidney test

12/10/2020

The Market Herald – Proteomics (ASX:PIQ) partners up with QIMR Berghofer Institute

09/10/2020

The West Australian – Proteomics JV developing blood test for oesophageal cancer

23/09/2020

Small Caps – Tony Locantro: what’s happening in the gold sector and 6 biotech stocks

18/08/2020

BioWorld – Proteomics rolls out blood-based diagnostic to predict diabetic kidney disease

30/07/2020

6PR (Audio) – How’s this! – a blood test that can predict you have diabetic kidney disease 4 years before you get it!

28/07/2020

The West Australian – Proteomics builds global patent protection for kidney test

19/06/2020

360Dx – Proteomics International Presents Study Data Supporting PromarkerD Kidney Disease Test

15/06/2020

Investor Insight – Proteomics International’s predictive test for diabetic kidney disease successfully validated in major clinical study

15/06/2020

The Market Herald – Proteomics (ASX:PIQ) validates prognostic diabetes kidney test

15/06/2020

Business News – Proteomics achieves clinical validation for kidney test

Subscribe
  • This field is for validation purposes and should be left unchanged.